What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Nanoparticle, Drug delivery, Nanotechnology, Biophysics and Chitosan.
His research in Nanoparticle intersects with topics in Conjugated system, Polymer, Biomedical engineering and Nuclear chemistry.
The study incorporates disciplines such as Confocal microscopy, Pharmacology and Ultrasound in addition to Drug delivery.
His Nanotechnology research includes elements of Molecular imaging, Cancer and Multimodal imaging.
Kwangmeyung Kim combines subjects such as In vitro, Biochemistry, Hyaluronic acid, Photosensitizer and Photodynamic therapy with his study of Biophysics.
His Chitosan research incorporates elements of Surface modification and Microparticle.
His most cited work include:
- Multifunctional nanoparticles for multimodal imaging and theragnosis (899 citations)
- Targeted delivery of low molecular drugs using chitosan and its derivatives. (578 citations)
- Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles (450 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Nanoparticle, Nanotechnology, Biophysics, Drug delivery and Cancer research.
His Nanoparticle research is multidisciplinary, incorporating perspectives in Chitosan, Fluorescence, Drug carrier and Biomedical engineering.
Kwangmeyung Kim interconnects Molecular imaging, Cancer therapy and Biodistribution in the investigation of issues within Nanotechnology.
His work is dedicated to discovering how Biophysics, Biochemistry are connected with Bioorthogonal chemistry and Click chemistry and other disciplines.
The Drug delivery study combines topics in areas such as Liposome, Pharmacology, Tumor targeting and Doxorubicin.
His biological study spans a wide range of topics, including Cancer cell, Cancer, Pathology and Cancer immunotherapy.
He most often published in these fields:
- Nanoparticle (36.22%)
- Nanotechnology (24.49%)
- Biophysics (22.19%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (19.64%)
- Nanoparticle (36.22%)
- Cancer cell (12.24%)
In recent papers he was focusing on the following fields of study:
Kwangmeyung Kim mainly focuses on Cancer research, Nanoparticle, Cancer cell, Biophysics and Cancer.
His work carried out in the field of Cancer research brings together such families of science as Doxorubicin, Immune system, Drug delivery and Cancer immunotherapy.
His Nanoparticle research is within the category of Nanotechnology.
His work deals with themes such as Photodynamic therapy and Surface modification, which intersect with Cancer cell.
His Biophysics research incorporates themes from Fluorescence, Bioorthogonal chemistry, Azide, Colloidal gold and Iron oxide.
Kwangmeyung Kim combines subjects such as Conjugated system, Photoacoustic spectroscopy, Biochemistry and Endocytosis with his study of Cancer.
Between 2017 and 2021, his most popular works were:
- Engineering nanoparticle strategies for effective cancer immunotherapy. (53 citations)
- Engineering nanoparticle strategies for effective cancer immunotherapy. (53 citations)
- Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy (33 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cancer research, Cancer cell, Cancer immunotherapy, Peptide and Immunogenic cell death.
The concepts of his Cancer research study are interwoven with issues in In vitro, Sudden death, Conjugated system, Cathepsin B and Nanomedicine.
His Cancer cell study frequently draws connections between adjacent fields such as Programmed cell death.
His research in Peptide intersects with topics in Cathepsin, Doxorubicin, Prodrug, Toxicity and Cytotoxicity.
His Immunogenic cell death study combines topics in areas such as Sonodynamic therapy, Adverse effect, Drug delivery, Necroptosis and Cytotoxic T cell.
His Cancer research is multidisciplinary, relying on both Imaging modalities and Tumor targeting.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
